The CYP3A4∗1B polymorphism and prostate cancer susceptibility in a Portuguese population
Authors:
- Ana NogalANAna Nogal
- Ana CoelhoACAna Coelho
- Raquel CatarinoRCRaquel Catarino
- António MoraisAMAntónio Morais
- Francisco LoboFLFrancisco Lobo
- Rui MedeirosRui Medeiros
- 1 September 2007
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 177 (2) , 149-152
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men☆Urologic Oncology: Seminars and Original Investigations, 2006
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- CYP3A4 , CYP3A5 , and CYP3A43 Genotypes and Haplotypes in the Etiology and Severity of Prostate CancerCancer Research, 2004
- CYP3A4 Polymorphisms--Potential Risk Factors for Breast and Prostate Cancer: A HuGE ReviewAmerican Journal of Epidemiology, 2004
- Cytochrome P450 3A and their regulationNaunyn-Schmiedeberg's Archives of Pharmacology, 2004
- Increased transcriptional activity of the CYP3A4*1B promoter variantEnvironmental and Molecular Mutagenesis, 2003
- Ethnic Differences in the Frequency of Prostate Cancer Susceptibility Alleles at SRD5A2 and CYP3A4Human Heredity, 2002
- More about: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.JNCI: Journal of the National Cancer Institute, 2000
- RESPONSE: Re: Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4JNCI: Journal of the National Cancer Institute, 1999
- Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4JNCI: Journal of the National Cancer Institute, 1998